Home / Resource Library / Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL

Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL

Study investigated circulating tumour DNA following treatment with odronextamab in follicular and DLBCL.